The effects of such dietary supplementation and of the aforementioned epidrugs during development remain to be tested in mouse models of ALS, with a focus on those that carry mutations in genes proven to be required for proper neurodevelopment, such as FUS, TARDBP, and C9ORF72 [139,140,141]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.